AbCellera Biologics (ABCL) Operating Margin (2020 - 2026)
AbCellera Biologics (ABCL) operating margin from Mar 31, 2020 to Mar 31, 2026. The current AbCellera Biologics (ABCL) operating margin is -691.35%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of AbCellera Biologics (ABCL)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | -288.97% | -73.53% |
| 2024 | -1091.81% | +75.04% |
| 2023 | -623.74% | -1498.45% |
| 2022 | 44.60% | -18.13% |
| 2021 | 54.48% | -18.59% |
| 2020 | 66.92% | -288.58% |
| 2019 | -35.49% | N/A |
Comparison AbCellera Biologics (ABCL) operating margin with competitors
AbCellera Biologics (ABCL) operating margin is -691.35%.